CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing ...
Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...
The CRISPR Cas9 gene editing tool — the genetic scissors that won the 2020 Nobel Prize in Chemistry — is essentially based on ...
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...
The investigational therapy will be used in Kyverna's KYSA-5 Phase 1/2 open-label, multicenter study to evaluate KYV-101 in adult patients with diffuse cutaneous systemic sclerosis (scleroderma) This ...
Science and Technology Minister Jitendra Singh on Wednesday launched Indias first indigenous CRISPR-based gene therapy for sickle cell disease, which particularly affects the countrys tribal ...
Union Minister of State (Independent Charge) for Science & Technology; Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh today ...
India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...
In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback